Table 3.

Incidence of melphalan toxicity and globe salvage with IVM treatment in 34 eyes of 26 patients with B-scan ultrasonography

	Anterior segment toxicity	Grade 1–3 toxicity	Grade 4–5 toxicity	Globe salvage
With PVD prior to IVM, of 10	0 (0)	6 (60)	1 (10)	8 (80)
Without PVD prior to IVM, of 15	0 (0)	5 (33)	1 (7)	11 (73)
Indeterminant PVD prior to IVM, of 9	4 (44)	3 (33)	2 (23)	8 (89)

PVD status is based on the status prior to IVM. Values are number of eyes (%). PVD, posterior vitreous detachment; IVM, intravitreal melphalan treatment.